Kanavit

Phytomenadione, the active ingredient in Kanavit, is a Vitamin K presented as an oral tablet for oral use. It is used to treat vitamin K deficiency, prevent bleeding in newborns, and reverse anticoagulation caused by vitamin K antagonists. GNH USA supplies Kanavit as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kanavit is a vitamin K agent that supports normal blood clotting pathways. - Vitamin K deficiency: restores adequate clotting factor activity to reduce bleeding risk. - Newborn prophylaxis: prevents hemorrhagic disease of the newborn by supplying essential vitamin K. - Anticoagulant reversal: counteracts the effects of warfarin and other vitamin K antagonists to normalize coagulation.

Adverse reactions may occur with oral vitamin K therapy.

Common Side Effects: - Bruising or mild bleeding at sites of minor trauma. - Nausea or mild gastrointestinal discomfort. - Transient headache. - Skin rash or mild pruritus. - Elevated liver enzymes (asymptomatic).

Serious or Rare Side Effects: - Anaphylactic reaction (rare). - Severe hypersensitivity with angioedema. - Acute hemolysis in susceptible individuals. - Unexplained severe bleeding despite therapy. - Thromboembolic events in patients with underlying clotting disorders.

Kanavit should be used with clinical monitoring and awareness of patient‑specific factors. - Pregnancy: use only if the potential benefit outweighs the risk; consult a healthcare professional. - Breastfeeding: consider infant exposure; discuss with a clinician. - Liver disease: monitor coagulation parameters closely. - Concomitant anticoagulants: adjust dosing and monitor INR or PT. - Storage: Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Phytomenadione may interact with several drug classes, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Warfarin or other vitamin K antagonists: may diminish anticoagulant effect. - Broad‑spectrum antibiotics (e.g., cephalosporins): can alter gut flora and affect vitamin K levels. - High‑dose vitamin E: may interfere with vitamin K–dependent clotting.

Moderate Interactions (Monitor Closely): - Statins (e.g., simvastatin): potential additive effect on liver enzymes. - Fibrates: may influence coagulation parameters. - Herbal supplements containing vitamin K (e.g., green leafy extracts): could reduce therapeutic need.